CASP3 and rheumatoid arthritis: In contrast to the amelioration of apoptotic factors observed after treatment with IVIg [70], another study reported that patients treated with TPO-RA (n = 42) had increased apoptotic activity, including increased PS exposure and caspase-3, -7, -8 and -9 compared to untreated patients (n = 40) [71].